Infectome: a platform to trace infectious triggers of autoimmunity.

Abstract:

:The "exposome" is a term recently used to describe all environmental factors, both exogenous and endogenous, which we are exposed to in a lifetime. It represents an important tool in the study of autoimmunity, complementing classical immunological research tools and cutting-edge genome wide association studies (GWAS). Recently, environmental wide association studies (EWAS) investigated the effect of environment in the development of diseases. Environmental triggers are largely subdivided into infectious and non-infectious agents. In this review, we introduce the concept of the "infectome", which is the part of the exposome referring to the collection of an individual's exposures to infectious agents. The infectome directly relates to geoepidemiological, serological and molecular evidence of the co-occurrence of several infectious agents associated with autoimmune diseases that may provide hints for the triggering factors responsible for the pathogenesis of autoimmunity. We discuss the implications that the investigation of the infectome may have for the understanding of microbial/host interactions in autoimmune diseases with long, pre-clinical phases. It may also contribute to the concept of the human body as a superorganism where the microbiome is part of the whole organism, as can be seen with mitochondria which existed as microbes prior to becoming organelles in eukaryotic cells of multicellular organisms over time. A similar argument can now be made in regard to normal intestinal flora, living in symbiosis within the host. We also provide practical examples as to how we can characterise and measure the totality of a disease-specific infectome, based on the experimental approaches employed from the "immunome" and "microbiome" projects.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Bogdanos DP,Smyk DS,Invernizzi P,Rigopoulou EI,Blank M,Pouria S,Shoenfeld Y

doi

10.1016/j.autrev.2012.12.005

subject

Has Abstract

pub_date

2013-05-01 00:00:00

pages

726-40

issue

7

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(12)00296-0

journal_volume

12

pub_type

杂志文章,评审
  • Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.

    abstract:OBJECTIVE:To describe safety and efficacy of rituximab in patients with systemic sclerosis. METHODS:We included 13 patients with systemic sclerosis treated with rituximab and pooled with 40 additional patients from the literature. SSc rituximab untreated patients were matched to rituximab treated ones. RESULTS:Thirte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2017.12.010

    authors: Thiebaut M,Launay D,Rivière S,Mahévas T,Bellakhal S,Hachulla E,Fain O,Mekinian A

    更新日期:2018-06-01 00:00:00

  • Anti-annexin V antibodies: are they prothrombotic?

    abstract::Annexin V inhibits prothrombin activation and is able to prevent thrombus formation under normal venous and arterial blood flow conditions. Antibodies to annexin V have been identified in association with several pathological conditions, including systemic lupus erythematosus (SLE) with or without anti-phospholipid sy...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2004.07.006

    authors: Esposito G,Tamby MC,Chanseaud Y,Servettaz A,Guillevin L,Mouthon L

    更新日期:2005-01-01 00:00:00

  • Complex regional pain syndrome - False hopes and miscommunications.

    abstract::Complex regional pain syndrome (CRPS) has been considered to be an autoimmune disease and there have been clinical trials with intravenous immunoglobulin. Often the etiology of the so-called CRPS diagnosis cannot be discerned and there are no validated instruments that provide functional metrics. The term complex regi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.10.003

    authors: Chang C,McDonnell P,Gershwin ME

    更新日期:2019-03-01 00:00:00

  • Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.

    abstract::Rheumatoid Arthritis (RA) is a complex systemic autoimmune disease in which various cell types are involved. Among them, neutrophils have been recognized as important players in the onset and the progression of RA. The pathogenic role of neutrophils in RA lies in the alteration of several processes, including increase...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.006

    authors: Cecchi I,Arias de la Rosa I,Menegatti E,Roccatello D,Collantes-Estevez E,Lopez-Pedrera C,Barbarroja N

    更新日期:2018-11-01 00:00:00

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

    abstract::The presence of anti-nuclear antibodies (ANA) is a hallmark of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and was recently recommended as the screening test of choice by a task force of the American College ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.005

    authors: Mahler M,Hanly JG,Fritzler MJ

    更新日期:2012-07-01 00:00:00

  • Use of rituximab in patients with systemic lupus erythematosus: an update.

    abstract::Systemic lupus erythematosus (SLE) is a chronic, occasionally life threatening, multisystem disorder. Patients suffer from a wide group of symptoms and have a variable prognosis that depends of the severity and type of organ involvement. The clinical manifestations include fever, skin lesions, arthritis, neurologic, r...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.11.006

    authors: García-Carrasco M,Jiménez-Hernández M,Escárcega RO,Mendoza-Pinto C,Galarza-Maldonado C,Sandoval-Cruz M,Zamudio-Huerta L,López-Colombo A,Cervera R

    更新日期:2009-02-01 00:00:00

  • Alzheimer's disease and Down's syndrome: treating two paths to dementia.

    abstract::Successful therapy of dementia, like any disease, depends upon understanding its pathogenesis. This review contrasts the dominant pathways to dementia which differ in Alzheimer's disease (AD) and in Down's syndrome (DS). Impaired clearance of neurotoxic amyloid beta peptides (Abeta) leads to dementia in AD. In DS over...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.10.013

    authors: Weksler ME,Szabo P,Relkin NR,Reidenberg MM,Weksler BB,Coppus AM

    更新日期:2013-04-01 00:00:00

  • Cellular players in angiogenesis during the course of systemic sclerosis.

    abstract::Vascular endothelial injury in Systemic Sclerosis (SSc) leads to pathological changes in the blood vessels that adversely impact the physiology of many organs, resulting in chronic tissue ischemia. The response to hypoxia induces complex cellular and molecular mechanisms in the attempt to recover endothelial cell func...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.016

    authors: Cipriani P,Marrelli A,Liakouli V,Di Benedetto P,Giacomelli R

    更新日期:2011-08-01 00:00:00

  • The needs of patients with systemic sclerosis--what are the difficulties encountered?

    abstract::When the diagnosis of systemic sclerosis (SSc) is made and you are told "You have SSc", it is a strange feeling for the patient, because you don't yet know what it is exactly. It is a very intense shock to hear this, and it is also difficult to try to imagine what will follow. There is no cure for SSc; there are just ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2010.09.009

    authors: Godard D

    更新日期:2011-03-01 00:00:00

  • Multiple sclerosis: geoepidemiology, genetics and the environment.

    abstract::Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been exte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.010

    authors: Milo R,Kahana E

    更新日期:2010-03-01 00:00:00

  • Mechanistic immunological based classification of rheumatoid arthritis.

    abstract::The classical autoimmunity paradigm in rheumatoid arthritis (RA) is strongly supported by immunogenetics suggesting follicular helper T-cell responses driving high titre specific autoantibodies that pre-dates disease onset. Using the immunological disease continuum model of inflammation against self with "pure" adapti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.001

    authors: McGonagle D,Watad A,Savic S

    更新日期:2018-11-01 00:00:00

  • The complex immunogenetic basis of systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology with a complex genetic basis that includes many susceptibility genes on multiple chromosomes. As complex human diseases like SLE involve multiple, interacting genetic and environmental determinants, identifying genes for complex tr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.01.001

    authors: Castro J,Balada E,Ordi-Ros J,Vilardell-Tarrés M

    更新日期:2008-05-01 00:00:00

  • Fecal calprotectin in systemic sclerosis and review of the literature.

    abstract::Fecal calprotectin (FC) is a simple, non-invasive and reproducible test, which has been described to be highly elevated in patients with active inflammatory bowel diseases. Recently, few authors have reported increased levels of FC in SSc patients, although the relationship between FC levels and the degree of gastroin...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.01.018

    authors: Marie I,Leroi AM,Menard JF,Levesque H,Quillard M,Ducrotte P

    更新日期:2015-06-01 00:00:00

  • The Mediterranean diet, fish oil supplements and Rheumatoid arthritis outcomes: evidence from clinical trials.

    abstract::The impact of dietary interventions such as specific types of diet or nutritional supplements in rheumatoid arthritis (RA) has been subject to increased attention in recent years. The recognition of the unmet need to better understand the effects of specific dietary interventions on disease outcomes in RA, along with ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.007

    authors: Petersson S,Philippou E,Rodomar C,Nikiphorou E

    更新日期:2018-11-01 00:00:00

  • Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

    abstract::Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory multisystem disease. The onset of viral and bacterial infections may favor the exacerbation of the disease, amplify autoimmune processes and contribute to mortality and morbidity. The prevention of influenza and Streptococcus pneumoniae infec...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.007

    authors: Murdaca G,Orsi A,Spanò F,Puppo F,Durando P,Icardi G,Ansaldi F

    更新日期:2014-02-01 00:00:00

  • Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism.

    abstract::Evidence for genes associated with risk for Type 1 diabetes (T1D) in the extended region of the major histocompatibility complex (MHC) genes is accumulating. The aim of this study was to investigate the association pattern of the extended MHC region with T1D susceptibility to identify effects independent of well estab...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.05.001

    authors: Jahromi MM

    更新日期:2012-12-01 00:00:00

  • Does seronegative antiphospholipid syndrome really exist?

    abstract::The diagnosis of seronegative (SN-) antiphospholipid syndrome (APS) has been suggested for patients with clinical manifestations indicative of APS but with persistently negative results in the commonly used assays to detect anti-cardiolipin (aCL) antibodies, anti-β2 Glycoprotein I antibodies (aβ2GPI), and lupus antico...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.10.017

    authors: Cervera R,Conti F,Doria A,Iaccarino L,Valesini G

    更新日期:2012-06-01 00:00:00

  • Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?

    abstract::Autoimmune rheumatic diseases (ARD) are prevalent in women during their childbearing age. For their treatment, high doses of corticosteroid (CS) for long-term periods are often required, increasing the risk of bone loss. According to recent guidelines, bisphosphonates (BP) should be used as first line treatment to pre...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.002

    authors: Losada I,Sartori L,Di Gianantonio E,Zen M,Clementi M,Doria A

    更新日期:2010-06-01 00:00:00

  • Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?

    abstract::Henoch-Schönlein purpura is the most common systemic vasculitis in childhood, characterized by the presence of immunoglobulin A deposits in the small vessels of skin, gastrointestinal tube, joints and kidneys. Although there have been great efforts made in elucidating its pathogenic mechanisms, Henoch-Schönlein purpur...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.04.003

    authors: Rigante D,Castellazzi L,Bosco A,Esposito S

    更新日期:2013-08-01 00:00:00

  • Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases.

    abstract::Systemic rheumatic diseases (SRDs) are associated with accelerated atherosclerosis. It has recently been recognised that chronic inflammation is an important factor in the development of atherosclerotic plaque and endothelial dysfunction. The levels of biomarkers such as serum pentraxin 3 (PTX3), an innate immunity pr...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.08.001

    authors: Atzeni F,Turiel M,Hollan I,Meroni P,Sitia S,Tomasoni L,Sarzi-Puttini P

    更新日期:2010-10-01 00:00:00

  • The role of T cell apoptosis in nervous system autoimmunity.

    abstract::Fas is a transmembrane receptor involved in the death program of several cell lines, including T lymphocytes. Deleterious mutations hitting genes involved in the Fas pathway cause the autoimmune lymphoprolipherative syndrome (ALPS). Moreover, defective Fas function is involved in the development of common autoimmune d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.08.011

    authors: Comi C,Fleetwood T,Dianzani U

    更新日期:2012-12-01 00:00:00

  • A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders.

    abstract::Musculoskeletal (MSK) disorders constitute one of the most common clinical presentations to clinical care givers. Within this category of illnesses, systemic autoimmune rheumatic diseases (SARD) such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjögren's syndrome (SjS) and rheumatoid arthritis (RA)...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.08.003

    authors: Stinton LM,Fritzler MJ

    更新日期:2007-11-01 00:00:00

  • Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.

    abstract::The aim of this study is to assess the long-term effectiveness and safety of IL1Ra in Schnitzler syndrome (SchS). Between 2010 and 2012, we performed a nationwide survey among French internal medicine departments to identify SchS patients. We retrospectively analyzed the long-term efficacy and safety of IL1Ra and the ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.autrev.2014.08.031

    authors: Néel A,Henry B,Barbarot S,Masseau A,Perrin F,Bernier C,Kyndt X,Puechal X,Weiller PJ,Decaux O,Ninet J,Hot A,Aouba A,Astudillo L,Berthelot JM,Bonnet F,Brisseau JM,Cador B,Closs-Prophette F,Dejoie T,de Korwin JD,Dh

    更新日期:2014-10-01 00:00:00

  • Hemopoietic stem cell transplantation in rheumatic diseases--an update.

    abstract::Hematopoietic stem cell transplant (HSCT) for autoimmune diseases has been recognized as a potential treatment for patients who have failed conventional therapy. Autologous (self) donor cells have been preferred over allogeneic (HLA-matched) cells for rescue after high dose immunotherapy, given the previous higher rat...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2005.03.003

    authors: de Buys P,Khanna D,Furst DE

    更新日期:2005-09-01 00:00:00

  • Treatment of rheumatoid arthritis with rituximab: an update and possible indications.

    abstract::Based on new biologic and clinical insights, the number of drugs blocking different biologic targets in rheumatoid arthritis (RA) [e.g., tumor necrosis factor alpha (TNFalpha), CTLA4, interleukin (IL)-1, IL-6, IL-15, IL-18, B lymphocyte stimulator (BLyS), CD20] has increased considerably over the last decade. Rituxima...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.007

    authors: De Vita S,Quartuccio L

    更新日期:2006-08-01 00:00:00

  • Environmental factors and the geoepidemiology of juvenile idiopathic arthritis.

    abstract::Juvenile idiopathic arthritis (JIA), the most common chronic rheumatic disease of childhood, is a clinically heterogeneous group of disorders characterized by chronic inflammatory arthritis. JIA is considered to be an autoimmune disease, which is a result of immune reaction caused or triggered by environmental factors...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.018

    authors: Berkun Y,Padeh S

    更新日期:2010-03-01 00:00:00

  • Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis.

    abstract::Autoimmune responses and inflammation are involved in the excess cardiovascular risk observed in patients with systemic inflammatory diseases. Autoimmune myocarditis is a presentation of an inflammatory reaction of the heart during the course of autoimmune disorders, with most cases seen in systemic lupus erythematosu...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.05.005

    authors: Mavrogeni S,Dimitroulas T,Kitas GD

    更新日期:2012-12-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Ocular involvement in granulomatosis with polyangiitis: A single-center cohort study on 63 patients.

    abstract:OBJECTIVE:To analyse the ocular manifestations of patients with GPA, their treatment and outcome. METHODS:Retrospective cohort study performed at the National Referral Center for Vasculitis, Cochin Hospital, Paris (France), from January 2005 to December 2015. Among 308 patients with a new diagnosis of GPA in accordanc...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2019.03.001

    authors: Pérez-Jacoiste Asín MA,Charles P,Rothschild PR,Terrier B,Brézin A,Mouthon L,Guillevin L,Puéchal X

    更新日期:2019-05-01 00:00:00

  • CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.

    abstract:BACKGROUND:Myositis is a heterogeneous group of muscular auto-immune diseases with clinical and pathological criteria that allow the classification of patients into different sub-groups. Inclusion body myositis is the most frequent myositis above fifty years of age. Diagnosing inclusion body myositis requires expertise...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2019.02.003

    authors: Dzangué-Tchoupou G,Mariampillai K,Bolko L,Amelin D,Mauhin W,Corneau A,Blanc C,Allenbach Y,Benveniste O

    更新日期:2019-04-01 00:00:00